Ac Immune Sa share price logo

Ac Immune Sa Share Price

NASDAQ: ACIU

Small Cap

$2.86

-0.02

(-0.69%)

as on

Ac Immune Sa Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.77
    $2.89
    downward going graph

    3.15%

    Downside

    1.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.43
    $4.00
    downward going graph

    50.00%

    Downside

    39.86%

    Upside

    downward going graph

Ac Immune Sa share price movements today

Previous Close
$2.88
Open
$2.86
Volume
430.8K
Day's Low - High
$2.77 - $2.89
52 Week Low - High
$1.43 - $4.00

Ac Immune Sa Historical Returns

1 Month Return
+ 4.35 %
3 Month Return
-7.99 %
1 Year Return
+ 45.45 %
3 Year Return
+ 29.73 %
5 Year Return
-62.89 %

Ac Immune Sa Stock Fundamentals & Key Indicators

Check Ac Immune Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$286.7M

EPS (TTM)

-0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-67.5M

Revenue (TTM)

3.6M

Profit Margin

0.00%

Return On Equity TTM

-89.65%

Ac Immune Sa vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ac Immune Sa with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Ac Immune Sa image
Ac Immune Sa
BUY$286.7M-62.89%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Ac Immune Sa Stock including INR - Dollar returns

The Ac Immune Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Ac Immune Sa investment value today

Current value as on today

₹1,53,985

Returns

₹53,985

(+53.99%)

Returns from Ac Immune Sa Stock

₹44,444 (+44.44%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Ac Immune Sa Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ac Immune Sa. Average target price of $9

Ac Immune Sa Share Price Target

Get share price movements and forecasts by analysts on Ac Immune Sa.

What analysts predicted

68.22%UPSIDE

Target Price

$9

Current Price

$2.86

Analyzed by

9 Analysts

Target

$9.00

Ac Immune Sa target price $9, a slight upside of 68.22% compared to current price of $2.86. According to 9 analysts rating.

Ac Immune Sa Stock’s Investor Sentiment and Interest

Search interest for Ac Immune Sa Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Ac Immune Sa Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
17
0
0
30
1
1
1
0
0
Gross Profit
-13
17
-17
0
30
1
1
1
0
0
Operating Income
-15
-3
-20
-20
7
-18
-19
-19
-16
-13
EBITDA
-14
-4
-17
-22
6
-15
-18
-20
-15
-13
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-4
-17
-22
5
-15
-19
-21
-15
-14
Income Tax Expense
0
0
0
-
-
0
-
-
-
-
Net Income
-16
-5
-20
-25
6
-17
-21
-21
-15
-14
Net Profit Margin
0.00%
-32.05%
-2600.00%
-3312.95%
21.59%
-1389.36%
-1922.12%
-1622.43%
-1688.82%
-4220.05%

Ac Immune Sa Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
22
20
7
112
17
1
4
17
30
3
Gross Profit
-2
-12
-37
61
-49
-67
4
-46
-39
3
Operating Income
-10
-22
-49
44
-61
-79
-70
-53
-52
-68
EBITDA
-6
-22
-49
45
-59
-70
-68
-51
-48
-63
Interest Expense
0
0
0
1
0
0
0
0
0
0
Depreciation
-
0
0
1
1
2
2
2
2
2
Income Before Tax
-7
-26
-50
45
-61
-72
-70
-54
-50
-70
Income Tax Expense
3
0
-1
1
0
0
0
0
0
-
Net Income
-6
-26
-51
46
-69
-79
-75
-62
-57
-67
Net Profit Margin
-30.57%
-130.39%
-708.24%
41.14%
-401.28%
-7732.63%
-1798.04%
-366.41%
-186.44%
-1883.01%

Ac Immune Sa Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
-17
-22
5
-15
-19
-21
-15
-14
Operating Cash Flow
-16
1
73
-14
5
-18
-15
-18
-16
Investing Cash Flow
23
-23
-75
-2
-3
3
23
20
15
Financing Cash Flow
41
0
0
0
0
0
0
0
0
Change in Cash
46
-21
-5
-19
3
-16
5
2
0

Ac Immune Sa Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-50
45
-61
-72
-70
-54
-50
-67
Operating Cash Flow
-22
-44
55
-59
-65
-73
-60
65
-66
Investing Cash Flow
-1
-32
-66
28
-53
23
65
-105
60
Financing Cash Flow
0
109
49
0
40
-1
43
-1
0
Change in Cash
-27
32
37
-32
-78
-50
46
-42
-4

Global Institutional Holdings in Ac Immune Sa

Funds
Holdings
Dimensional Fund Advisors, Inc.
0.21%
Geode Capital Management, LLC
0.06%
Acadian Asset Management LLC
0.41%
Wells Fargo & Co
0.99%
Susquehanna International Group, LLP
0.02%
See all

Insights on Ac Immune Sa

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ACIU has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ACIU has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -21.18M → -14.26M (in $), with an average increase of 22.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.30M → 338.0K (in $), with an average decrease of 46.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ACIU stock has moved down by -6.8%

About Ac Immune Sa

ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
OrganisationAc Immune Sa
HeadquartersBuilding B, Lausanne, Switzerland, 1015
IndustryHealth Technology
CEODr. Andrea Pfeifer Ph.D.
E-voting on sharesClick here to vote

Key Management of Ac Immune Sa

Name

Title

Mr. Mark Danton

Executive Vice President of Information Systems & Artificial Intelligence

Dr. Günther Staffler Ph.D.

Executive Vice President of Development

Mr. Christopher Roberts

CFO & VP of Finance

Mr. Piergiorgio Donati

Chief Technical Operations Officer

Dr. Oliver Sol M.D.

VP & Head of Clinical Development

Dr. Julien Rongere Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

Dr. Andrea Pfeifer Ph.D.

Co-Founder, CEO & Director

Dr. Gary Anthony Waanders Ph.D.

Senior VP of Investor Relations & Corporate Communications

Dr. Matthias Maurer Ph.D.

Senior VP & General Counsel

FAQs

What is Ac Immune Sa share price today?

Ac Immune Sa share price today is $2.86 as on at the close of the market. Ac Immune Sa share today touched a day high of $2.89 and a low of $2.77.

What is the 52 week high and 52 week low for Ac Immune Sa share?

Ac Immune Sa share touched a 52 week high of $4 on and a 52 week low of $1.43 on . Ac Immune Sa stock price today i.e. is closed at $2.86,which is 28.50% down from its 52 week high and 100.01% up from its 52 week low.

What is Ac Immune Sa's market capitalisation today?

Ac Immune Sa market capitalisation is $0.00T as on .

How to invest in Ac Immune Sa Stock (ACIU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ac Immune Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ac Immune Sa Shares that will get you 0.5245 shares as per Ac Immune Sa share price of $2.86 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ac Immune Sa Stock (ACIU) from India?

Indian investors can start investing in Ac Immune Sa (ACIU) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Ac Immune Sa stock (as per the Rupee-Dollar exchange rate as on ). Based on Ac Immune Sa share’s latest price of $2.86 as on March 25, 2026 at 1:29 am IST, you will get 3.4965 shares of Ac Immune Sa. Learn more about fractional shares .

What are the returns that Ac Immune Sa has given to Indian investors in the last 5 years?

Ac Immune Sa stock has given -62.89% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?